Drug intelligence / Profile preview

Gailiang Shenzhu Guanxin Fang

Development stage
Preclinical
Administration
Oral
01

Overview

A Traditional Chinese Medicine (TCM) herbal compound, Gailiang Shenzhu Guanxin Fang is primarily indicated for the treatment of coronary heart disease (CHD), including stable angina pectoris. Its therapeutic effects are rooted in TCM principles, aiming to invigorate qi, eliminate phlegm, and promote blood circulation. This multi-ingredient formulation is believed to improve microcirculation, reduce blood viscosity, and exert antioxidant properties, thereby alleviating symptoms and improving cardiac function in patients with CHD.

Other names
改良的参术冠心方Shenzhu Guanxin Recipe GranulesShenzhu Guanxin Recipe参术冠心方颗粒参术冠心方
02

Targets

JUN (Transcription factor Jun)STAT3 (Signal Transducer and Activator of Transcription 3)IL-6 (Interleukin 6)RELA (Nuclear Factor Kappa B Subunit p65)MAPK14 (p38 mitogen-activated protein kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)EGFR T790M (Epidermal growth factor receptor T790M mutant)CASP3 (Caspase-3)

Beyond the preview

Go deeper on Gailiang Shenzhu Guanxin Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gailiang Shenzhu Guanxin Fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call